Research ArticleMolecular Imaging
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes
Simone Krebs, Afruja Ahad, Lukas M. Carter, Justin Eyquem, Christian Brand, Meghan Bell, Vladimir Ponomarev, Thomas Reiner, Claude F. Meares, Stephen Gottschalk, Michel Sadelain, Steven M. Larson and Wolfgang A. Weber
Journal of Nuclear Medicine December 2018, 59 (12) 1894-1900; DOI: https://doi.org/10.2967/jnumed.118.208041
Simone Krebs
1Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Afruja Ahad
1Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Lukas M. Carter
2Radiochemistry and Molecular Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Justin Eyquem
3Center for Cell Engineering and Immunology Program, Sloan Kettering Institute, New York, New York
Christian Brand
2Radiochemistry and Molecular Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Meghan Bell
1Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Vladimir Ponomarev
2Radiochemistry and Molecular Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Thomas Reiner
2Radiochemistry and Molecular Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Claude F. Meares
4Chemistry Department, University of California, Davis, California
Stephen Gottschalk
5Department of Bone Marrow Transplant and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, Tennessee; and
Michel Sadelain
3Center for Cell Engineering and Immunology Program, Sloan Kettering Institute, New York, New York
Steven M. Larson
1Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Wolfgang A. Weber
1Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
6Department of Nuclear Medicine, Technical University of Munich, Munich, Germany

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 59, Issue 12
December 1, 2018
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes
Simone Krebs, Afruja Ahad, Lukas M. Carter, Justin Eyquem, Christian Brand, Meghan Bell, Vladimir Ponomarev, Thomas Reiner, Claude F. Meares, Stephen Gottschalk, Michel Sadelain, Steven M. Larson, Wolfgang A. Weber
Journal of Nuclear Medicine Dec 2018, 59 (12) 1894-1900; DOI: 10.2967/jnumed.118.208041
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes
Simone Krebs, Afruja Ahad, Lukas M. Carter, Justin Eyquem, Christian Brand, Meghan Bell, Vladimir Ponomarev, Thomas Reiner, Claude F. Meares, Stephen Gottschalk, Michel Sadelain, Steven M. Larson, Wolfgang A. Weber
Journal of Nuclear Medicine Dec 2018, 59 (12) 1894-1900; DOI: 10.2967/jnumed.118.208041
Jump to section
Related Articles
Cited By...
- IL13R{alpha}2-Targeting Antibodies for Immuno-PET in Solid Malignancies
- Imaging cellular immunotherapies and immune cell biomarkers: from preclinical studies to patients
- Pretargeting: A Path Forward for Radioimmunotherapy
- PET/MRI Improves Management of Children with Cancer
- Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET
- Imaging of CAR T-Cells in Cancer Patients: Paving the Way to Treatment Monitoring and Outcome Prediction
- Reporter Genes for PET Imaging of CAR T Cells Offers Insight into Adoptive Cell Transfer